Physiogenex will be presenting its innovative NASH animal models on January 10th-11th, 2020 at the NASH-TAG 2020 conference in Park City, UT, USA.
Dr François Briand, our Director of Research and Development, will be presenting 2 posters during the 2-day conference and will give an oral presentation about Physiogenex innovative preclinical NASH models on Saturday January the 11th, 2020 during the Free Paper Session: 6:15pm-6:30pm.
Feel free to contact us if you wish to meet Dr. Briand and/or discuss your drug development projects with us.
Physiogenex is a leading preclinical research organization providing non clinical services in metabolic disorders and complications.
We offer in vivo translational diseases models as well as ex vivo assays to support efficacy and pharmacological assays. We have a strong expertise on metabolic diseases, diabetes, insulin resistance, obesity, dyslipidemia, liver diseases (NASH to fibrosis) and renal complications.